Johnson Investment Counsel’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-43,600
| Closed | -$419K | – | 847 |
|
|
2024
Q4 | $419K | Hold |
43,600
| – | – | ﹤0.01% | 562 |
|
|
2024
Q3 | $125K | Hold |
43,600
| – | – | ﹤0.01% | 786 |
|
|
2024
Q2 | $127K | Sell |
43,600
-3,158
| -7% | -$9.22K | ﹤0.01% | 741 |
|
|
2024
Q1 | $149K | Hold |
46,758
| – | – | ﹤0.01% | 737 |
|
|
2023
Q4 | $157K | Hold |
46,758
| – | – | ﹤0.01% | 691 |
|
|
2023
Q3 | $111K | Hold |
46,758
| – | – | ﹤0.01% | 658 |
|
|
2023
Q2 | $82.3K | Hold |
46,758
| – | – | ﹤0.01% | 660 |
|
|
2023
Q1 | $144K | Hold |
46,758
| – | – | ﹤0.01% | 642 |
|
|
2022
Q4 | $248K | Hold |
46,758
| – | – | ﹤0.01% | 587 |
|
|
2022
Q3 | $165K | Hold |
46,758
| – | – | ﹤0.01% | 618 |
|
|
2022
Q2 | $121K | Hold |
46,758
| – | – | ﹤0.01% | 630 |
|
|
2022
Q1 | $209K | Hold |
46,758
| – | – | ﹤0.01% | 634 |
|
|
2021
Q4 | $318K | Hold |
46,758
| – | – | ﹤0.01% | 550 |
|
|
2021
Q3 | $341K | Hold |
46,758
| – | – | ﹤0.01% | 520 |
|
|
2021
Q2 | $469K | Hold |
46,758
| – | – | 0.01% | 454 |
|
|
2021
Q1 | $447K | Buy |
+46,758
| New | +$447K | 0.01% | 441 |
|